Trademark: 87401227
Word
AXANTIA
Status
Registered
Status Code
700
Status Date
Tuesday, September 18, 2018
Serial Number
87401227
Registration Number
5563523
Registration Date
Tuesday, September 18, 2018
Mark Type
4000
Filing Date
Thursday, April 6, 2017
Published for Opposition
Tuesday, April 3, 2018

Trademark Owner History

Classifications
40 Custom manufacture of pharmaceuticals
5 Pharmaceutical preparations, namely, antibacterial pharmaceuticals and antidiabetic pharmaceuticals for the treatment of pain and fever, asthma, depression, diabetes, epilepsy, allergies, hypercholesterolemia, hypertension, bacterial infections, heart attacks and strokes, psychotic conditions, peptic ulcer, viral infections, emesis, fungal infections, cold and cough, dermatitis, skin whitening, erectile dysfunction, acne, flatulence, topical inflammation, blood flow, neuropathy, prostate hyperplasia, teething aid, angina pectoris, multiple sclerosis, skin tissue regeneration and burn, rheumatoid arthritis and other musculoskeletal disorders, neuropathic pain, weight reduction, chronic obstructive pulmonary disease, and for general anesthesia purposes; sanitary preparations for medical purposes; and food for babies
42 Development of pharmaceutical preparations and medicines; Pharmaceutical product evaluation; Pharmaceutical research services; Testing of pharmaceuticals; Laboratory research services relating to pharmaceuticals

Trademark Events
Sep 18, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Sep 18, 2018
Registered-Principal Register
Aug 12, 2018
Extension Of Time To Oppose Process - Terminated
Apr 27, 2018
Extension Of Time To Oppose Received
Apr 3, 2018
Official Gazette Publication Confirmation E-Mailed
Apr 3, 2018
Published For Opposition
Mar 14, 2018
Notification Of Notice Of Publication E-Mailed
Feb 28, 2018
Approved For Pub - Principal Register
Feb 28, 2018
Examiner's Amendment Entered
Feb 28, 2018
Notification Of Examiners Amendment E-Mailed
Feb 28, 2018
Examiners Amendment E-Mailed
Feb 28, 2018
Examiners Amendment -Written
Feb 20, 2018
Notification Of Letter Of Suspension E-Mailed
Feb 20, 2018
Letter Of Suspension E-Mailed
Feb 20, 2018
Suspension Letter Written
Jan 24, 2018
Assigned To Examiner
Jan 20, 2018
Teas/Email Correspondence Entered
Jan 20, 2018
Correspondence Received In Law Office
Jan 15, 2018
Assigned To Lie
Dec 28, 2017
Teas Response To Office Action Received
Jun 28, 2017
Notification Of Non-Final Action E-Mailed
Jun 28, 2017
Non-Final Action E-Mailed
Jun 28, 2017
Non-Final Action Written
Jun 28, 2017
Assigned To Examiner
Apr 13, 2017
New Application Office Supplied Data Entered
Apr 10, 2017
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24